Title:
AMIDE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2015/002230
Kind Code:
A1
Abstract:
The present invention relates to compounds (I), which have RORγt inhibitory effects, and salts thereof. In formula (I), each notation is as described in the Specification. (I)
More Like This:
| WO/1993/001163 | AMINO ACID DERIVATIVE |
| WO/2007/098503 | ALISKIREN NITRATE SALT |
| JP5026655 | Medium-chain fatty acids, glycerides and analogs as neutrophil survival and activators |
Inventors:
YAMAMOTO SATOSHI (JP)
SHIRAI JUNYA (JP)
KOUNO MITSUNORI (JP)
TOMATA YOSHIHIDE (JP)
SATO AYUMU (JP)
OCHIDA ATSUKO (JP)
FUKASE YOSHIYUKI (US)
FUKUMOTO SHOJI (JP)
ODA TSUNEO (JP)
TOKUHARA HIDEKAZU (JP)
ISHII NAOKI (JP)
SASAKI YUSUKE (JP)
SHIRAI JUNYA (JP)
KOUNO MITSUNORI (JP)
TOMATA YOSHIHIDE (JP)
SATO AYUMU (JP)
OCHIDA ATSUKO (JP)
FUKASE YOSHIYUKI (US)
FUKUMOTO SHOJI (JP)
ODA TSUNEO (JP)
TOKUHARA HIDEKAZU (JP)
ISHII NAOKI (JP)
SASAKI YUSUKE (JP)
Application Number:
PCT/JP2014/067649
Publication Date:
January 08, 2015
Filing Date:
July 02, 2014
Export Citation:
Assignee:
TAKEDA PHARMACEUTICAL (JP)
International Classes:
C07C237/22; A61K31/167; A61K31/341; A61K31/351; A61K31/381; A61K31/382; A61K31/397; A61K31/40; A61K31/4015; A61K31/407; A61K31/416; A61K31/4166; A61K31/42; A61K31/421; A61K31/4245; A61K31/426; A61K31/4406; A61K31/445; A61K31/45; A61K31/455; A61K31/50; A61K31/505; A61K31/5375; A61K31/695; A61P1/04; A61P17/06; A61P19/02; A61P25/00; A61P29/00; A61P43/00; C07D205/04; C07D207/12; C07D207/277; C07D211/88; C07D213/82; C07D233/34; C07D239/36; C07D239/52; C07D263/20; C07D263/40; C07D271/10; C07D277/20; C07D277/56; C07D295/18; C07D307/68; C07D309/06; C07D333/48; C07D335/02; C07D401/12; C07D403/12; C07D405/12; C07D409/12; C07D413/12; C07D487/04; C07F7/10; C07F7/12; C07F7/30; C07K5/065
Domestic Patent References:
| WO2013100027A1 | 2013-07-04 | |||
| WO2009019508A1 | 2009-02-12 | |||
| WO2005120497A2 | 2005-12-22 | |||
| WO2001044226A1 | 2001-06-21 | |||
| WO2013018695A1 | 2013-02-07 | |||
| WO2013042782A1 | 2013-03-28 | |||
| WO2004108892A2 | 2004-12-16 | |||
| WO2001055106A2 | 2001-08-02 | |||
| WO1999037667A1 | 1999-07-29 | |||
| WO2013042782A1 | 2013-03-28 | |||
| WO2013100027A1 | 2013-07-04 | |||
| WO2010013161A1 | 2010-02-04 | |||
| WO2009095324A1 | 2009-08-06 | |||
| WO2010142752A1 | 2010-12-16 |
Foreign References:
| FR2860793A1 | 2005-04-15 | |||
| EP1341035A2 | 2003-09-03 |
Other References:
JOURNAL OF COMBINATORIAL CHEMISTRY, vol. 12, no. 4, 2010, pages 414 - 416
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 19, no. 12, 2009, pages 3247 - 3252
"Jikken Kagaku Kouza", vol. 22, 1991
"Molecule Design", vol. 7, 1990, HIROKAWA SHOTEN, article "Development of Pharmaceutical Products", pages: 163 - 198
JOURNAL OF ANTIBIOTICS, vol. 38, 1985, pages 877 - 885
CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 38, 1990, pages 2792 - 2796
See also references of EP 3018123A4
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 19, no. 12, 2009, pages 3247 - 3252
"Jikken Kagaku Kouza", vol. 22, 1991
"Molecule Design", vol. 7, 1990, HIROKAWA SHOTEN, article "Development of Pharmaceutical Products", pages: 163 - 198
JOURNAL OF ANTIBIOTICS, vol. 38, 1985, pages 877 - 885
CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 38, 1990, pages 2792 - 2796
See also references of EP 3018123A4
Attorney, Agent or Firm:
TAKASHIMA, HAJIME (JP)
Takashima 1 (JP)
Takashima 1 (JP)
Download PDF: